Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 85
- Hemp Industry
Could Pakistan Become the Next Market to Legalise Medical Cannabis?
Pakistan is set to become that latest country to launch a medical cannabis industry, as its National Assembly gets poised to vote through a landmark reform bill.
- Uncategorized
Legal Battle Erupts in Missouri Over Governor’s Controversial Hemp Ban
Missouri’s hemp industry is fighting to prevent a comprehensive ban on all intoxicating hemp substances as tensions continue to rise between the nation’s hemp and cannabis industries.
- Adult-Use
Trump Publicly Supports Cannabis Legalization in Florida
Donald Trump has extended his public support for cannabis reform, this time taking to his social media platform, Truth Social, to endorse the upcoming legalization vote in Florida.
- Uncategorized
Deutsche Ärzte bleiben bei der Verschreibung von medizinischem Cannabis zurückhaltend, obwohl neue Regeln den Zugang für Millionen von Menschen öffnen
Letzten Monat schlug der Gemeinsame Bundesausschuss (G-BA) wesentliche Änderungen des Verschreibungsverfahrens für medizinisches Cannabis vor und öffnete damit die Tür für die Verschreibung von medizinischem Cannabis über die gesetzliche Krankenversicherung (GKV).
- Medical
German Doctors May Remain Cautious of Prescribing Medical Cannabis Despite New Rules Opening Up Access For Millions
Last month, Germany’s Federal Joint Committee (G-BA) proposed significant changes to the medical cannabis prescription process, opening the door for medical cannabis to be prescribed via statutory health insurance (gesetzliche Krankenversicherung or GKV) This would enable around 70% of practicing German physicians to prescribe medical cannabis without prior approval from health insurance companies, which would…
- Uncategorized
SNDL to Acquire Indiva’s Cannabis Assets After Stalking Horse Bid
SNDL Inc. has been selected as the successful bidder for the acquisition of Indiva Limited’s business and assets, following proceedings under Canada’s Companies’ Creditors Arrangement Act (CCAA).
- Uncategorized
Cannabis Industry Consolidates as New Markets Drive Licensing Growth
Cannabis business license applications have grown for the first time in over a year in Q2, but the total number of active licenses continues its downward trend across the US and Canada, according to a new report from CRB Monitor.
- Uncategorized
Rufe nach einer Einschränkung der Verschreibung von medizinischem Cannabis in Deutschland werden lauter, da der florierende Markt keine Anzeichen einer Verlangsamung zeigt
Die Verschreibungen von medizinischem Cannabis sind in Deutschland seit dem 01.
- Medical
Calls to Restrict Medical Cannabis Prescriptions in Germany Grow as the Flourishing Market Shows No Signs of Slowing Down
Medical cannabis prescriptions have exploded across Germany since April 01 when its landmark CanG Act was brought into force.
- Press releases
Cosma S.A. and SOMAÍ Pharmaceuticals partner to Revolutionize Poland with the most Innovative Cannabis-Based Solutions
Cosma S.A., a leader in cannabis-based pharmaceutical advancements, and SOMAÍ Pharmaceuticals, a fully vertically integrated Multi-Country Operator (MCO) in the global medical cannabis markets, are thrilled to announce a strategic partnership that designates Cosma as the Marketing Authorization Holder (MAH) for both Cosma and SOMAÍ’s cutting-edge cannabis-based products.
- Hemp Industry
New York Hemp Retailers Allege ‘Unjust Treatment’ in Fresh Lawsuit as State Crackdown Hammers Illicit Market
New York’s Office of Cannabis Management (OCM) has had yet another lawsuit filed against them as the city’s attempted crackdown on illicit cannabis stores continues to receive pushback.
- Markets & Stocks
Jazz Fails Phase 3 Trial in Japan, BAT Set to See Growth From Cannabis Investment, & DanCann Pharma Reports First Profit
Jazz Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”JAZZ” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] The pharmaceutical giant announced last week that its flagship cannabinoid treatment, Epidyolex, failed to pass its Phase 3 clinical trial in Japan.
